If the claim is rejected or not covered by the patient's primary commercial insurance: Leave the primary claim as rejected and submit to SS&C Health as secondary payer using the BIN/PCN/GRP/ID found on the savings offer and with an other coverage code 03
People who have diabetes are already at risk for NAION, whether they use semaglutide or not
Some conditions and medications may interact with semaglutide, and your healthcare provider will need to evaluate the potential risks and benefits of this treatment for your specific situation
Sharing a 94% structural homology with native human GLP-1, Semaglutide is distinguished by three modifications: 1) amino-acid substitutions at position 8 (alanine to -aminoisobutyric acid or Aib) and position 34 (lysine to arginine), and acylation of the lysine in position 26 with a spacer consisting of two 8-amino-3,6-dioxaoctanoic acid (ADO) moieties, a glutamic acid moiety, and a C-18 fatty di-acid side chain (Lau et al., 2015)
Both medications can slow gastric emptying, which may affect how quickly oral medications (including the contraceptive pill) are absorbed
.jpg)
